Paper Details

  1. Home
  2. Paper Details

Mecasermin: new drug. Insufficient improvement in statural growth.

Author:

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study reviews mecasermin, a recombinant IGF-1, for the treatment of primary IGF-1 deficiency. While mecasermin has been shown to have limited clinical benefits, it carries potential risks such as hypoglycemia, headache, intracranial hypertension, and organ hypertrophy.
Paper Details　
Original Abstract of the Article :
(1) Human insulin-like growth factor type 1 (IGF-1) is the main effector of growth hormone action. Primary IGF-1 deficiency is a rare disease, mainly resulting in very short stature; (2) Mecasermin is a recombinant IGF-1 marketed for this indication as a twice daily subcutaneous injection; (3) Clini...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/19637420

データ提供：米国国立医学図書館（NLM）

Mecasermin: A New Drug with Limited Benefits: A Desert Mirage?

Growth hormone deficiency, a challenging condition affecting children's growth, requires effective treatments. This research, like a traveler encountering a shimmering mirage in the desert, examines the effectiveness of mecasermin, a new drug designed to address this condition.

Limited Growth Improvement: A Disappointing Discovery

The study highlights the limited effectiveness of mecasermin in promoting growth in children with growth hormone deficiency. This is like finding a small puddle of water in a vast desert, offering little relief from thirst.

Potential Side Effects: A Cautionary Tale

The authors also acknowledge the potential side effects associated with mecasermin, including hypoglycemia, headache, and intracranial hypertension. This is like encountering a prickly cactus in the desert, reminding us of the potential risks of any new treatment.

Dr. Camel's Conclusion

This research suggests that mecasermin, while a promising new treatment, falls short of expectations. Its limited effectiveness and potential side effects raise concerns about its overall value.

Date :
  1. Date Completed 2009-08-20
  2. Date Revised 2009-07-28
Further Info :

Pubmed ID

19637420

DOI: Digital Object Identifier

19637420

Related Literature

Article Analysis
・Effects of mecasermin injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.